Matches in SemOpenAlex for { <https://semopenalex.org/work/W1569759551> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W1569759551 endingPage "1176" @default.
- W1569759551 startingPage "1168" @default.
- W1569759551 abstract "Abstract GSK1322322 is the first in a new class of antibiotics that targets peptide deformylase (PDF), an essential bacterial enzyme required for protein maturation. This randomized, double‐blind, placebo‐controlled, eight‐cohort phase I trial enrolled 62 healthy volunteers to assess safety, tolerability, and pharmacokinetic profiles of GSK1322322. GSK1322322 was administered as a single oral or intravenous (IV) dose, escalating from 500 to 3,000 mg or repeat IV doses escalating from 500 to 1,500 mg twice daily. Upon repeat IV administration, GSK1322322 exhibits linear pharmacokinetics over time upon repeat doses as shown by time‐invariant pharmacokinetics. A dose‐proportional increase in area under concentration‐time curve was observed after single or repeat IV dosing, whereas clearance at steady state remained generally unchanged across doses. There was minimal accumulation of GSK1322322 after repeat IV twice‐daily administration. After oral tablet doses of GSK1322322 1,000 and 1,500 mg, absolute bioavailability was 69% and 56%, respectively. GSK1322322 administration at single and repeat IV doses and at supratherapeutic single IV doses of 2,000 and 3,000 mg was associated with mild‐to‐moderate drug‐related adverse events. On the basis of the pharmacokinetics and tolerability demonstrated in this study, GSK1322322 has the potential to become the first‐in‐class PDF inhibitor for clinical use." @default.
- W1569759551 created "2016-06-24" @default.
- W1569759551 creator A5066296310 @default.
- W1569759551 creator A5072952672 @default.
- W1569759551 creator A5075105680 @default.
- W1569759551 creator A5090913588 @default.
- W1569759551 creator A5091035436 @default.
- W1569759551 date "2013-08-13" @default.
- W1569759551 modified "2023-10-16" @default.
- W1569759551 title "Safety, tolerability, and pharmacokinetics of oral and intravenous administration of GSK1322322, a peptide deformylase inhibitor" @default.
- W1569759551 cites W1502497970 @default.
- W1569759551 cites W1793731243 @default.
- W1569759551 cites W2033380245 @default.
- W1569759551 cites W2060749971 @default.
- W1569759551 cites W2064667003 @default.
- W1569759551 cites W2104484219 @default.
- W1569759551 cites W2108638835 @default.
- W1569759551 cites W2127809526 @default.
- W1569759551 cites W2157805245 @default.
- W1569759551 cites W2170919860 @default.
- W1569759551 doi "https://doi.org/10.1002/jcph.150" @default.
- W1569759551 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23907665" @default.
- W1569759551 hasPublicationYear "2013" @default.
- W1569759551 type Work @default.
- W1569759551 sameAs 1569759551 @default.
- W1569759551 citedByCount "12" @default.
- W1569759551 countsByYear W15697595512014 @default.
- W1569759551 countsByYear W15697595512015 @default.
- W1569759551 countsByYear W15697595512016 @default.
- W1569759551 countsByYear W15697595512017 @default.
- W1569759551 countsByYear W15697595512021 @default.
- W1569759551 crossrefType "journal-article" @default.
- W1569759551 hasAuthorship W1569759551A5066296310 @default.
- W1569759551 hasAuthorship W1569759551A5072952672 @default.
- W1569759551 hasAuthorship W1569759551A5075105680 @default.
- W1569759551 hasAuthorship W1569759551A5090913588 @default.
- W1569759551 hasAuthorship W1569759551A5091035436 @default.
- W1569759551 hasConcept C112705442 @default.
- W1569759551 hasConcept C142724271 @default.
- W1569759551 hasConcept C181389837 @default.
- W1569759551 hasConcept C197934379 @default.
- W1569759551 hasConcept C204787440 @default.
- W1569759551 hasConcept C27081682 @default.
- W1569759551 hasConcept C2777056448 @default.
- W1569759551 hasConcept C2777288759 @default.
- W1569759551 hasConcept C2778375690 @default.
- W1569759551 hasConcept C71924100 @default.
- W1569759551 hasConcept C98274493 @default.
- W1569759551 hasConceptScore W1569759551C112705442 @default.
- W1569759551 hasConceptScore W1569759551C142724271 @default.
- W1569759551 hasConceptScore W1569759551C181389837 @default.
- W1569759551 hasConceptScore W1569759551C197934379 @default.
- W1569759551 hasConceptScore W1569759551C204787440 @default.
- W1569759551 hasConceptScore W1569759551C27081682 @default.
- W1569759551 hasConceptScore W1569759551C2777056448 @default.
- W1569759551 hasConceptScore W1569759551C2777288759 @default.
- W1569759551 hasConceptScore W1569759551C2778375690 @default.
- W1569759551 hasConceptScore W1569759551C71924100 @default.
- W1569759551 hasConceptScore W1569759551C98274493 @default.
- W1569759551 hasIssue "11" @default.
- W1569759551 hasLocation W15697595511 @default.
- W1569759551 hasLocation W15697595512 @default.
- W1569759551 hasOpenAccess W1569759551 @default.
- W1569759551 hasPrimaryLocation W15697595511 @default.
- W1569759551 hasRelatedWork W16113689 @default.
- W1569759551 hasRelatedWork W1990788570 @default.
- W1569759551 hasRelatedWork W2022148560 @default.
- W1569759551 hasRelatedWork W2073311134 @default.
- W1569759551 hasRelatedWork W2143815486 @default.
- W1569759551 hasRelatedWork W2314489661 @default.
- W1569759551 hasRelatedWork W2365953299 @default.
- W1569759551 hasRelatedWork W2391021644 @default.
- W1569759551 hasRelatedWork W2437352158 @default.
- W1569759551 hasRelatedWork W2081375274 @default.
- W1569759551 hasVolume "53" @default.
- W1569759551 isParatext "false" @default.
- W1569759551 isRetracted "false" @default.
- W1569759551 magId "1569759551" @default.
- W1569759551 workType "article" @default.